Welcome Message

We welcome you to the prestigious 7^th International  Eye and Vision Congress on 09-10, May 2024 in Barcelona, Spain.

We work on the theme “Gene Therapy Breakthroughs in Vision” which is meant to suggest new thinking, processes and strategies that have a legitimate impact on how you work together and your agency.

Eye 2024 is the stage for renowned researchers, specialists, Physicians university professors, professionals and students, including the address. No other occasion can provide a remarkable glimpse of keynote speakers, quality colleagues, and connection to content. This is an attractive opportunity for representatives of universities and institutes to cooperate with researchers. Passionate members can affirm their cooperation by strengthening the group with their partners.

About Conference

We are excited to announce the upcoming eye conference, set to take place on May 09-10, 2024, in the vibrant city of Barcelona, Spain. This conference will be a unique gathering of esteemed professionals, researchers, and experts in the field of ophthalmology, all united by a shared passion for advancing eye care through groundbreaking gene therapy innovations.

It's an opportunity for revered professionals, pioneering researchers, and thought leaders in ophthalmology to unite and ignite a revolution in gene therapy.Come let us join the event  together and make it successful.

Sessions & Tracks

Session1: Gene Therapy in Ophthalmology

Gene therapy in ophthalmology is propelling transformative advancements, offering hope for treating inherited eye diseases. This personalized precision approach, facilitated by emerging viral vector technologies, holds promise in restoring vision for those affected by conditions like Leber congenital amaurosis (LCA), retinitis pigmentosa, and choroideremia. Clinical successes underscore its potential, as patients have shown remarkable improvements, perceiving light, shapes, and even reading letters on an eye chart post-treatment.

Collaborative efforts among geneticists, ophthalmologists, and researchers fuel the field's progress. While challenges persist, such as refining vector delivery and ensuring affordability, gene therapy's trajectory promises a future where untreatable eye conditions can be managed or even cured through gene-based interventions. As clinical trials yield promising results, gene therapy reshapes ophthalmology's landscape, lighting a path towards a world where vision is not just a dream, but a tangible reality.

Session2:Artificial Intelligence and Machine Learning in Eye Care

Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing the landscape of eye care, ushering in a new era of precision diagnosis, personalized treatment, and improved patient outcomes. With the ability to process vast amounts of data and extract meaningful insights, these technologies are transforming how eye conditions are detected, monitored, and managed.

AI-powered algorithms analyze vast amounts of data, including medical images and patient records, to assist ophthalmologists in detecting and diagnosing eye conditions with unprecedented accuracy. Through pattern recognition and predictive analytics, AI identifies subtle changes that may elude the human eye, enabling early intervention. Utilizing AI algorithms for disease detection, diagnosis, and treatment planning.The trajectory of AI and ML in eye care is promising, marked by a continuous stream of innovations. As technology bridges gaps in expertise, geographical distances, and diagnostic accuracy, it reaffirms AI's role as an invaluable ally in safeguarding vision and transforming the field of ophthalmology.

Session3:Myopia Control and Management

Orthokeratology (Ortho-K) is a non-surgical approach that involves wearing specially designed gas-permeable contact lenses overnight. These lenses reshape the cornea temporarily, providing clear vision during the day without the need for glasses or lenses. Ortho-K has been found to slow down myopia progression, especially in children and adolescents.

Atropine Eye Drops are used to dilate the pupil and relax the focusing mechanism of the eye. Research suggests that atropine can effectively slow down myopia progression. Advances in formulation have reduced side effects, making it a viable option for management.

Session4:Teleophthalmology and Remote Patient Care

Teleophthalmology, a branch of telemedicine, is transforming the way eye care is delivered by leveraging technology to provide remote diagnosis, consultation, and treatment to patients. This approach is particularly valuable in addressing issues of accessibility, reducing barriers to care, and ensuring timely interventions, especially for individuals in remote or underserved areas. Through teleophthalmology, healthcare providers can offer efficient and effective remote patient care for a range of eye conditions.

Teleophthalmology is revolutionizing eye care by enabling remote patient care, early diagnosis, and continuous monitoring. By leveraging technology to bridge the gap between patients and healthcare providers, teleophthalmology holds the potential to enhance accessibility, improve patient outcomes, and contribute to the overall advancement of eye care services.

Session5:Retinal Imaging and Diagnostics

Fundus photography involves capturing high-resolution images of the retina's surface using specialized cameras. These images are invaluable for identifying retinal abnormalities, such as tears, diabetic retinopathy, and macular degeneration.

Fluorescein angiography is a technique where a fluorescent dye is injected into the bloodstream. As the dye circulates through the retinal blood vessels, a series of photographs capture its movement. This helps in identifying vascular issues like leakage or blockages, often seen in diabetic retinopathy and macular degeneration.Indocyanine Green Angiography (ICGA) is similar but uses a different dye that fluoresces under infrared light. It's particularly helpful for visualizing deeper retinal layers, aiding in the assessment of conditions affecting the choroid.

Session6: Minimally Invasive Glaucoma Surgery (MIGS)

Minimally Invasive Glaucoma Surgery (MIGS) has emerged as a groundbreaking advancement within ophthalmology, presenting a safer and less intrusive approach to addressing glaucoma, a serious eye ailment. By focusing on reducing intraocular pressure (IOP) – a central factor in glaucoma's advancement – MIGS procedures work to augment the eye's natural drainage pathways. Ultimately, MIGS is reshaping the landscape of glaucoma management by delivering safer, minimally invasive alternatives. These innovations not only improve patient outcomes but also elevate the overall quality of life for those grappling with glaucoma. This marks a substantial stride forward in the realm of ophthalmic care.

Session7:Innovations in Corneal Health and Surgery

Recent advancements in corneal health and surgery have transformed the landscape of ophthalmology, offering new hope and improved outcomes for individuals with various eye conditions. Cutting-edge diagnostic technologies, like optical coherence tomography (OCT), enable precise visualization of corneal structures, aiding in the accurate diagnosis of disorders such as keratoconus and corneal dystrophies. Surgical techniques have also evolved, with custom laser procedures and endothelial keratoplasty options providing tailored solutions for patients. Moreover, regenerative therapies and artificial corneas are on the horizon, promising innovative approaches to corneal repair and transplantation.

Session8 : Neuro-ophthalmology and Visual Pathway Disorders

Neuro-ophthalmology is a specialized field that focuses on the complex relationship between the visual system and the brain. It deals with disorders that affect both the eye and the neurological pathways responsible for vision. The visual pathway, which includes the eyes, optic nerves, and brain structures, is intricate and can be susceptible to various conditions that can lead to visual disturbances. Neuro-ophthalmologists are trained to diagnose and manage these disorders, which often require a multidisciplinary approach involving neurology and ophthalmology. Diagnostic tools in neuro-ophthalmology have evolved significantly, with advanced imaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT), allowing for detailed visualization of the brain and optic pathways. These tools aid in identifying structural abnormalities, inflammation, or other underlying causes of visual problems.

Session9: Emerging Technologies in Ophthalmic Surgery

The field of ophthalmic surgery is undergoing a significant transformation, driven by a wave of emerging technologies. These innovations are revolutionizing the way eye conditions are managed, diagnosed, and treated. From laser-assisted cataract surgery that improves accuracy to robotic systems that enhance surgical precision, these advancements are reshaping the landscape of ophthalmic surgery. Technologies like adaptive optics imaging allow for incredibly detailed views of retinal structures, aiding in early detection and management of various eye conditions. Similarly, micro-invasive glaucoma surgery (MIGS) devices and gene therapies are pushing the boundaries of what's possible in terms of minimally invasive treatments and addressing inherited retinal disorders. Artificial intelligence is becoming an integral part of diagnostics, analyzing retinal images and providing accurate diagnoses, while intraoperative OCT and 3D visualization systems are enhancing surgical planning and execution. These innovations collectively hold the promise of not only improved surgical outcomes but also a more precise and personalized approach to treating eye conditions, ultimately improving the quality of life for countless patients.

Session10: Ocular Surface Health and Dry Eye Management

One of the notable innovations in this field is the refinement of tear film assessment techniques. Tear breakup time (TBUT), a method used to measure how long tears remain stable on the eye's surface, provides valuable insights into tear film stability. Additionally, tear osmolarity measurements offer a quantifiable metric for evaluating the concentration of dissolved particles in tears, aiding in the diagnosis of dry eye severity.

In the realm of treatment, an array of options has emerged, ranging from advanced artificial tears to novel therapeutic interventions. For those with evaporative dry eye resulting from meibomian gland dysfunction, LipiFlow therapy has gained prominence. This innovative treatment applies localized heat and gentle pressure to the eyelids, effectively unclogging blocked meibomian glands and restoring the lipid layer of the tear film.

Session11: Personalized Medicine in Ophthalmology

Personalized medicine, a groundbreaking approach that tailors medical care to an individual's unique characteristics, is making significant strides in the field of ophthalmology. This innovative concept acknowledges that each patient has distinct genetic, lifestyle, and environmental factors that influence their eye health and disease susceptibility. By leveraging this personalized approach, ophthalmologists can offer more precise and effective diagnoses, treatments, and management strategies.

Genetic profiling is a cornerstone of personalized medicine in ophthalmology. Genetic testing can identify specific gene variations associated with eye conditions, enabling early detection and tailored interventions. For example, genetic markers linked to age-related macular degeneration (AMD) or glaucoma risk can guide preventative measures and customized treatment plans.

Session12: Regenerative Medicine and Stem Cell Therapy

In recent years, regenerative medicine and stem cell therapy have emerged as transformative approaches in the field of ophthalmology. These innovative techniques hold the promise of repairing damaged eye tissues, restoring vision, and revolutionizing the treatment of various eye conditions. Research and applications of regenerative techniques for treating ocular diseases.

In addition to stem cell transplantation, emerging techniques like tissue engineering are advancing the field of regenerative ophthalmology. By combining stem cells with specialized scaffolds, researchers can create functional tissues for transplantation. This approach has the potential to revolutionize corneal, retinal, and even optic nerve regeneration.

Session13: Pediatric Ophthalmology and Strabismus

Pediatric ophthalmology is a specialized branch of eye care that focuses on the unique visual needs and eye health of children. The field encompasses a wide range of conditions, from routine eye exams for infants to the management of complex eyedisorders in children and adolescents. One of the most common issues addressed in pediatric ophthalmology is strabismus, a condition characterized by misalignment of the eyes.Strabismus, commonly known as "crossed eyes" or "lazy eyes," occurs when the eyes do not align properly and point in different directions. This misalignment can be present from birth or develop during childhood. Strabismus can have various causes, including problems with eye muscles, nerve control, or visual development

Market Analysis

The generation's increased risk of visual impairment is attributed to their dependence on the usage of modern devices. People rely on these platforms for entertainment, news, and even social updates from pals, despite the fact that they often work as PC experts. In the ebb and flow condition, 253 million people have vision impedance, 36 million have visual impairment, and 217 million have severe to direct vision impairment.It is common to find that people over 50 have significant vision impairments, and 81% of this age group has yearly confusion. In addition to these problems, chronic eye conditions are the main cause of visual impairment. The two main causes of the visual impedance are accounted for as untreated waterfall and uncorrected refractive errors.The leading cause of visual insufficiency in low- and middle-income countries continues to be untreated waterfall. However, efforts and advancements in the fields of optometry and vision science have decreased the number of ocular disorders and diseases. Over the past five years, intractable eye diseases like trachoma and onchocerciasis have significantly decreased, and it is now clear that over 80% of all vision loss may be prevented or treated.